BROWN BROTHERS HARRIMAN & CO

Position in INCY — Incyte Corp

CIK 14661 NEW YORK, NY

Position in INCY

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$182,310

+$69,021 QoQ

Shares Held

1,937

+68.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BROWN BROTHERS HARRIMAN & CO holds $9,680,711 across 45 Biotechnology names. INCY ranks #8 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,838	$2,606,900
2	PCVX	Vaxcyte, Inc.	38,033	$2,210,097
3	RVMD	Revolution Medicines, Inc.	15,000	$1,458,750
4	REGN	Regeneron Pharmaceuticals, Inc.	1,802	$1,392,297
5	ADMA	Adma Biologics, Inc.	39,973	$360,156
6	TECH	BIO-TECHNE Corp	6,724	$351,396
7	MRNA	Moderna, Inc.	6,843	$347,624
8	INCY	Incyte Corp This page	1,937	$182,310

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$182,310	1,937	+68.9%	Shares	Sole	2026-05-14
2025-12-31	$113,289	1,147	+40.2%	Shares	Sole	2026-02-12
2025-09-30	$69,374	818	+43.5%	Shares	Sole	2025-11-13
2025-06-30	$38,817	570	+432.7%	Shares	Sole	2025-08-11
2025-03-31	$6,478	107	+59.7%	Shares	Sole	2025-05-14
2024-12-31	$4,627	67	+644.4%	Shares	Sole	2025-02-12
2023-06-30	$560	9	-18.2%	Shares	Sole	2023-08-07
2023-03-31	$794	11	-83.8%	Shares	Sole	2023-05-11
2022-12-31	$5,461	68	0.0%	Shares	Sole	2023-02-09
2022-09-30	$4,531	68	+15.3%	Shares	Sole	2022-11-14
2022-06-30	$4,482	59	+126.9%	Shares	Sole	2022-08-11
2021-03-31	$2,113	26	+44.4%	Shares	Sole	2021-05-13
2020-09-30	$1,615	18	0.0%	Shares	Sole	2020-11-16
2020-06-30	$1,871	18	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.